InfuSystem Holdings, Inc. (INFU)

Market Cap	274.19M +34.8%
Revenue (ttm)	144.44M +2.4%
Net Income	9.44M +70.9%
EPS	0.44 +69.7%
Shares Out	20.03M
PE Ratio	31.10
Forward PE	25.91
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,222
Open	13.44
Previous Close	13.56
Day's Range	13.32 - 13.87
52-Week Range	7.29 - 14.64
Beta	1.38
Analysts	Strong Buy
Price Target	16.83 (+22.94%)
Earnings Date	Nov 5, 2026

About INFU

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 473
• Stock Exchange: NYSE American
• Ticker Symbol: INFU
• Website: https://www.infusystem.com

Financial Performance

In 2025, InfuSystem Holdings's revenue was $143.44 million, an increase of 6.36% compared to the previous year's $134.86 million. Earnings were $6.63 million, an increase of 182.60%.

Analyst Summary

According to 3 analysts, the average rating for INFU stock is "Strong Buy." The 12-month stock price target is $16.83, which is an increase of 22.94% from the latest price.

Price Target

$16.83

(22.94% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 7, 2026

Data Sources Report a data error